Cite
HARVARD Citation
Baert, F. et al. (2016). Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial. Gut. 65 (7), pp. 1126-1131. [Online].